Treatment of Active Pulmonary Tuberculosis in Adults: Current Standards and Recent Advances

Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs

(2009) T. Gumbo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption

(2008) J. J. Wilkins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Identification of Mutations Related to Streptomycin Resistance in Clinical Isolates of Mycobacterium tuberculosis and Possible Involvement of Efflux Mechanism

(2008) F. S. Spies et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Tuberculosis in Poorly Controlled Type 2 Diabetes: Altered Cytokine Expression in Peripheral White Blood Cells

(2008) Blanca I. Restrepo et al.   CLINICAL INFECTIOUS DISEASES

Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007

(2008) N. Sarita Shah   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies

(2008) Christie Y Jeon et al.   PLOS MEDICINE